Neuroepo multisession
…nemar.on003194) The quest for neuroprotection in Parkinson’s disease (PD) has…
- Participants
- 15
- Size
- 189 MB
- Version
- vv1.0.0
- Updated
- Nov 10, 2026
100 results for "neuroprotection" · page 1 of 10 · ranked by relevance
…nemar.on003194) The quest for neuroprotection in Parkinson’s disease (PD) has…
…nemar.on003195) The quest for neuroprotection in Parkinson’s disease (PD) has…
Multisession EEG and clinical dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (an erythropoietin formulation) in patients with Parkinson's disease. Participants were assessed at baseline and 9 months after the intervention, with cumulative NeuroEPO dose quantified and placebo coded as zero. The dataset supports analysis of treatment exposure, EEG-derived measures, and motor outcomes (MDS-UPDRS III).
Multisession EEG dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (erythropoietin-derived formulation) in patients with Parkinson's disease. Clinical (MDS-UPDRS III) and EEG assessments were acquired at baseline and 9 months after completing the intervention. Cumulative NeuroEPO dose is coded per participant (placebo = 0), enabling analysis of treatment effects on brain activity.
EEG recordings from a Probabilistic Selection Task (PST) collected in two studies: 80 healthy participants plus 5 pilot placebo sessions, and a double-blind cabergoline (1.25 mg) challenge study with 27 completers. Data were collected circa 2012-2013 at Brown University and share a sample with a previously published study on conflict as an implicit cost in reinforcement learning. The dataset supports research on reinforcement learning, dopamine, and feedback processing.
This case study records physiological and EEG data from a self-described practitioner of energy medicine who performed directed therapeutic intent on live and damaged cells. Across 60 double-blind treatment and control sessions, cell types (live, dead/x-rayed, or medium only) were randomized and concealed from both the practitioner and the experimenter. Matched control cells treated by a sham therapist provide behavioral measures of cellular outcomes.
EEG dataset from a reinforcement learning study of 50 healthy controls, 25 tested after a sad mood manipulation and 25 after a happy mood manipulation. Participants completed a probabilistic selection task with training and testing phases. The task was adapted from a Parkinsonism reinforcement learning paradigm, and the mood manipulation was delivered before each training block.
Six-hour tethered EEG recordings from wildtype and Syngap+/Δ-GAP heterozygous rats (male, 12-16 weeks old), collected between zeitgeber times 3 and 9 under a 12:12 light-dark cycle. Recordings used a head-mounted 32-channel EEG array with accelerometers, sampled at 1 kHz. Most animals have two recording sessions. The data support study of SYNGAP1-related neurodevelopmental pathophysiology.
Simultaneous EEG-fMRI dataset from 18 participants who played two games (a face game and a maze game) during wakefulness in a 3T MRI scanner. One game was randomly assigned to be won (reward) and the other lost (no reward). Participants then slept in the scanner with 64-channel EEG for 1-2 hours. A classifier trained on game-session data was applied to sleep-session fMRI to examine reward-biased spontaneous neural reactivation, and memory for both tasks was tested the next day.
EEG recordings from an executive functioning battery comprising the N-Back, Sustained Attention to Response Task (SART), and Local-Global tasks. Data were collected from 24 participants in two sessions, on the first and last day of a frontal midline theta neurofeedback meditation training experiment, to assess neurofeedback effects on executive function. Data are provided in EEGLAB .set format, with the original .bdf files in the sourcedata folder.